Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000 - luralembic is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; hyprolose; microcrystalline cellulose; maize starch; silicon dioxide; indigo carmine aluminium lake - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 10 mg - tablet, uncoated - excipient ingredients: crospovidone; magnesium stearate; maize starch; lactose monohydrate; microcrystalline cellulose; hyprolose; silicon dioxide; iron oxide red - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 15 mg - tablet, uncoated - excipient ingredients: magnesium stearate; crospovidone; lactose monohydrate; silicon dioxide; maize starch; hyprolose; microcrystalline cellulose; colour - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 20 mg - tablet, uncoated - excipient ingredients: hyprolose; silicon dioxide; maize starch; magnesium stearate; lactose monohydrate; crospovidone; microcrystalline cellulose - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 30 mg - tablet, uncoated - excipient ingredients: magnesium stearate; silicon dioxide; maize starch; lactose monohydrate; hyprolose; crospovidone; microcrystalline cellulose; iron oxide red - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 20 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; crospovidone; hyprolose; maize starch; silicon dioxide - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 10 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; crospovidone; hyprolose; maize starch; silicon dioxide; magnesium stearate; microcrystalline cellulose; iron oxide red - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 15 mg - tablet, uncoated - excipient ingredients: hyprolose; lactose monohydrate; maize starch; microcrystalline cellulose; magnesium stearate; silicon dioxide; crospovidone; colour - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 30 mg - tablet, uncoated - excipient ingredients: magnesium stearate; crospovidone; hyprolose; lactose monohydrate; silicon dioxide; microcrystalline cellulose; maize starch; iron oxide red - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.